• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与HSIX1过表达相关的G2细胞周期检查点的废除:乳腺癌发生的一种可能机制。

Abrogation of the G2 cell cycle checkpoint associated with overexpression of HSIX1: a possible mechanism of breast carcinogenesis.

作者信息

Ford H L, Kabingu E N, Bump E A, Mutter G L, Pardee A B

机构信息

Dana-Farber Cancer Institute and Harvard Medical School, 44 Binney Street, Boston, MA 02115, USA.

出版信息

Proc Natl Acad Sci U S A. 1998 Oct 13;95(21):12608-13. doi: 10.1073/pnas.95.21.12608.

DOI:10.1073/pnas.95.21.12608
PMID:9770533
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC22878/
Abstract

While conducting a search for cell cycle-regulated genes in human mammary carcinoma cells, we identified HSIX1, a recently discovered member of a new homeobox gene subfamily. HSIX1 expression was absent at the onset of and increased toward the end of S phase. Since its expression pattern is suggestive of a role after S phase, we investigated the effect of HSIX1 in the G2 cell cycle checkpoint. Overexpression of HSIX1 in MCF7 cells abrogated the G2 cell cycle checkpoint in response to x-ray irradiation. HSIX1 expression was absent or very low in normal mammary tissue, but was high in 44% of primary breast cancers and 90% of metastatic lesions. In addition, HSIX1 was expressed in a variety of cancer cell lines, suggesting an important function in multiple tumor types. These data support the role for homeobox genes in tumorigenesis/tumor progression, possibly through a cell cycle function.

摘要

在对人乳腺癌细胞中细胞周期调控基因进行搜索时,我们鉴定出了HSIX1,它是一个新的同源框基因亚家族中最近发现的成员。HSIX1在S期开始时不存在,而在S期末期表达增加。由于其表达模式提示在S期之后发挥作用,我们研究了HSIX1在G2细胞周期检查点中的作用。MCF7细胞中HSIX1的过表达消除了对X射线照射的G2细胞周期检查点。HSIX1在正常乳腺组织中不存在或表达非常低,但在44%的原发性乳腺癌和90%的转移病灶中高表达。此外,HSIX1在多种癌细胞系中表达,提示其在多种肿瘤类型中具有重要功能。这些数据支持同源框基因在肿瘤发生/肿瘤进展中的作用,可能是通过细胞周期功能实现的。

相似文献

1
Abrogation of the G2 cell cycle checkpoint associated with overexpression of HSIX1: a possible mechanism of breast carcinogenesis.与HSIX1过表达相关的G2细胞周期检查点的废除:乳腺癌发生的一种可能机制。
Proc Natl Acad Sci U S A. 1998 Oct 13;95(21):12608-13. doi: 10.1073/pnas.95.21.12608.
2
Cell cycle-regulated phosphorylation of the human SIX1 homeodomain protein.
J Biol Chem. 2000 Jul 21;275(29):22245-54. doi: 10.1074/jbc.M002446200.
3
Study of the G2/M cell cycle checkpoint in irradiated mammary epithelial cells overexpressing Cul-4A gene.过表达Cul-4A基因的受辐照乳腺上皮细胞中G2/M细胞周期检查点的研究
Int J Radiat Oncol Biol Phys. 2002 Mar 1;52(3):822-30. doi: 10.1016/s0360-3016(01)02739-0.
4
Ionizing radiation inhibits the PLK cell cycle gene in a G2 checkpoint-dependent manner.电离辐射以依赖G2检查点的方式抑制PLK细胞周期基因。
Anticancer Res. 2004 Mar-Apr;24(2B):555-62.
5
Both DNA topoisomerase II-binding protein 1 and BRCA1 regulate the G2-M cell cycle checkpoint.DNA拓扑异构酶II结合蛋白1和BRCA1均调控G2-M细胞周期检查点。
Cancer Res. 2003 Jun 15;63(12):3049-53.
6
CHFR-associated early G2/M checkpoint defects in breast cancer cells.乳腺癌细胞中与CHFR相关的早期G2/M期检查点缺陷。
Mol Carcinog. 2004 Jan;39(1):26-33. doi: 10.1002/mc.10161.
7
Examination of POU homeobox gene expression in human breast cancer cells.
Int J Cancer. 1999 Mar 31;81(1):104-12. doi: 10.1002/(sici)1097-0215(19990331)81:1<104::aid-ijc18>3.0.co;2-q.
8
High frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancer.14-3-3西格玛基因座的高甲基化频率导致乳腺癌中的基因沉默。
Proc Natl Acad Sci U S A. 2000 May 23;97(11):6049-54. doi: 10.1073/pnas.100566997.
9
Homeobox genes: potential candidates for the transcriptional control of the transformed and invasive phenotype.同源异型盒基因:转化和侵袭性表型转录调控的潜在候选基因。
Biochem Pharmacol. 1994 Jan 13;47(1):137-43. doi: 10.1016/0006-2952(94)90447-2.
10
UCN-01: a potent abrogator of G2 checkpoint function in cancer cells with disrupted p53.UCN - 01:一种能有效消除p53功能紊乱的癌细胞中G2检查点功能的物质。
J Natl Cancer Inst. 1996 Jul 17;88(14):956-65. doi: 10.1093/jnci/88.14.956.

引用本文的文献

1
Deubiquitinase-dependent transcriptional silencing controls inflammation.去泛素化酶依赖性转录沉默控制炎症。
Cell Res. 2025 Jul 3. doi: 10.1038/s41422-025-01140-5.
2
eIF3d and eIF3e mediate selective translational control of hypoxia that can be inhibited by novel small molecules.真核生物翻译起始因子3d(eIF3d)和真核生物翻译起始因子3e(eIF3e)介导缺氧的选择性翻译控制,而这种控制可被新型小分子抑制。
bioRxiv. 2025 May 29:2025.05.29.656739. doi: 10.1101/2025.05.29.656739.
3
Myogenesis gone awry: the role of developmental pathways in rhabdomyosarcoma.肌生成紊乱:发育途径在横纹肌肉瘤中的作用
Front Cell Dev Biol. 2025 Jan 20;12:1521523. doi: 10.3389/fcell.2024.1521523. eCollection 2024.
4
Targeting sine oculis homeoprotein 1 (SIX1): A review of oncogenic roles and potential natural product therapeutics.靶向无眼同源蛋白1(SIX1):致癌作用及潜在天然产物疗法综述
Heliyon. 2024 Jun 17;10(12):e33204. doi: 10.1016/j.heliyon.2024.e33204. eCollection 2024 Jun 30.
5
Biochemical characterization of the Eya and PP2A-B55α interaction.Eya 和 PP2A-B55α 相互作用的生化特性分析。
J Biol Chem. 2024 Jul;300(7):107408. doi: 10.1016/j.jbc.2024.107408. Epub 2024 May 23.
6
All eyes on Eya: A unique transcriptional co-activator and phosphatase in cancer.聚焦 Eya:癌症中的独特转录共激活因子和磷酸酶。
Biochim Biophys Acta Rev Cancer. 2024 May;1879(3):189098. doi: 10.1016/j.bbcan.2024.189098. Epub 2024 Mar 28.
7
In Vitro Phosphatase Assays for the Eya2 Tyrosine Phosphatase.体外磷酸酶分析用于研究 Eya2 酪氨酸磷酸酶
Methods Mol Biol. 2024;2743:285-300. doi: 10.1007/978-1-0716-3569-8_18.
8
Upregulation of the oestrogen target gene SIX1 is associated with higher growth speed and decreased survival in HCV-positive women with hepatocellular carcinoma.雌激素靶基因SIX1的上调与丙型肝炎病毒阳性的肝细胞癌女性患者的较高生长速度和较低生存率相关。
Oncol Lett. 2022 Sep 21;24(5):395. doi: 10.3892/ol.2022.13515. eCollection 2022 Nov.
9
SIX1 Activation Is Involved in Cell Proliferation, Migration, and Anti-inflammation of Acute Ischemia/Reperfusion Injury in Mice.SIX1激活参与小鼠急性缺血/再灌注损伤的细胞增殖、迁移和抗炎作用。
Front Mol Biosci. 2021 Aug 26;8:725319. doi: 10.3389/fmolb.2021.725319. eCollection 2021.
10
The SIX Family of Transcription Factors: Common Themes Integrating Developmental and Cancer Biology.转录因子的SIX家族:整合发育生物学和癌症生物学的共同主题
Front Cell Dev Biol. 2021 Aug 19;9:707854. doi: 10.3389/fcell.2021.707854. eCollection 2021.

本文引用的文献

1
Fission yeast rad12+ regulates cell cycle checkpoint control and is homologous to the Bloom's syndrome disease gene.裂殖酵母rad12+调节细胞周期检查点控制,并且与布卢姆综合征致病基因同源。
Mol Cell Biol. 1998 May;18(5):2721-8. doi: 10.1128/MCB.18.5.2721.
2
A direct-sequencing-based strategy for identifying and cloning cDNAs from differential display gels.一种基于直接测序的从差异显示凝胶中鉴定和克隆cDNA的策略。
Methods Mol Biol. 1997;85:77-85. doi: 10.1385/0-89603-489-5:77.
3
Expression genetics in cancer: shifting the focus from DNA to RNA.癌症中的表达遗传学:将焦点从DNA转移到RNA。
Proc Natl Acad Sci U S A. 1997 Feb 4;94(3):952-5. doi: 10.1073/pnas.94.3.952.
4
HOX11 interacts with protein phosphatases PP2A and PP1 and disrupts a G2/M cell-cycle checkpoint.HOX11与蛋白磷酸酶PP2A和PP1相互作用,并破坏G2/M细胞周期检查点。
Nature. 1997 Jan 30;385(6615):454-8. doi: 10.1038/385454a0.
5
p21WAF1/CIP1/SDI1 is elevated through a p53-independent pathway by mimosine.含羞草碱通过一条不依赖p53的途径使p21WAF1/CIP1/SDI1升高。
Cell Growth Differ. 1996 Jul;7(7):893-901.
6
The role of HOX homeobox genes in normal and leukemic hematopoiesis.HOX同源框基因在正常和白血病造血过程中的作用。
Stem Cells. 1996 May;14(3):281-91. doi: 10.1002/stem.140281.
7
The effect of the Fanconi anemia polypeptide, FAC, upon p53 induction and G2 checkpoint regulation.范可尼贫血多肽FAC对p53诱导及G2期检查点调控的影响。
Blood. 1996 Aug 1;88(3):1019-25.
8
Cloning of the human SIX1 gene and its assignment to chromosome 14.人类SIX1基因的克隆及其在14号染色体上的定位。
Genomics. 1996 Apr 1;33(1):140-2. doi: 10.1006/geno.1996.0172.
9
PAX genes: what's new in developmental biology and cancer?PAX基因:发育生物学和癌症领域有哪些新进展?
Hum Mol Genet. 1995;4 Spec No:1717-20. doi: 10.1093/hmg/4.suppl_1.1717.
10
The Drosophila sine oculis locus encodes a homeodomain-containing protein required for the development of the entire visual system.果蝇无眼基因座编码一种整个视觉系统发育所需的含同源结构域的蛋白质。
Neuron. 1994 May;12(5):977-96. doi: 10.1016/0896-6273(94)90308-5.